SERRA RX 260 is an ultra powerful proteolytic serrapeptase enzyme formula that stands alone in supporting healthy fibrin, mucous and inflammation levels in the body. Serrapeptase, originally the enzyme derived from the intestine of silkworms and used to dissolve the cocoons, is long known for its ability to break down proteins. Our cutting edge enteric coating technology makes Serra RX 260 unique. We dont use plastics or plastic capsules (phthalate free) in our enteric coatings to prevent health-related issues. Instead, we use Methacrylic Acid Copolymer (MAAC) a high quality, gastro-resistant, thoroughly safe enteric coating which allows the Serra RX 260 to reach the small intestine with higher activity to ensure maximum systemic enzyme therapy. Serra RX 260 consists of the worlds strongest enteric coated serrapeptase on the market for human consumption.* – POWERFUL SYSTEMIC SUPPLEMENT: Serra-RX contains a potent 260,000 SPU of Serrapeptase (also known as Serratiopeptidase) per serving.* – ACID-RESISTANT: Serrapeptase in Serra-RX has a completely phthalate-free polymer applied to maximize efficacy.* – SUPPORTS HEALTHY INFLAMMATORY RESPONSE & FIBRIN METABOLISM: Proteolytic activity supports the bodys ability to break down proteins, lessen the effects of inflammation in the body, and promote scar tissue health.* – PROMOTES HEALTHY RESPIRATORY, SINUS FUNCTION & POST SURGERY RECOVERY: An all-natural systemic enzyme like Serrapeptase supports healthy blood flow and viscosity, immune cell response, and sinus and respiratory build-up of mucus in lung conditions.* – QUALITY & PURITY YOU CAN TRUST: Manufactured in the USA. Free of wheat, egg, milk, soy, tree nuts, peanuts, fish, shellfish, and sesame.
Características do produto
Marca: Biomedic Labs RX
Características principais
Modelo
|
Biomedic Labs RX |
---|
Formato de venda
Formato do suplemento
|
Cápsula |
---|---|
Volume da unidade
|
0. 34 fl oz |
Características gerais
Marca
|
Biomedic Labs RX |
---|
Outros
Idade mínima recomendada
|
4 anos |
---|
Avaliações
Não há avaliações ainda.